Merck Announces That IMPROVE-IT Achieved Primary Endpoint; Data To Be Presented At American Heart Association Scientific Sessions Today

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today said that IMPROVE-IT met its primary endpoint. The results ...